Useful but costly treatment puts focus on budget
Finna-arvio
Useful but costly treatment puts focus on budget
Tallennettuna:
| Kieli |
suomi |
|---|---|
| Huomautukset |
Strong evidence indicates that ranibizumab slows the loss of visual acuity in patients with age-related macular degeneration. English supplement Medical science & practice : special joint newsletter from SBU and Finohta, s. 1-15. |
| Luokitus | |
| Aiheet/asiasanat |
